Latest news with #JurassicPark


Time of India
a day ago
- Entertainment
- Time of India
Ramayana producer talks about taking the Ranbir Kapoor-Yash starrer global; says Hollywood always saw us as poor and victim: 'That's not who we are'
Namit Malhotra, known for his VFX work in Hollywood hits like *Dune* and *Inception*, is producing a two-part *Ramayana* epic aiming to redefine India's global cinematic identity. Inspired by *Jurassic Park*, Malhotra seeks to showcase Indian culture's strength, moving beyond narratives of poverty. The film boasts Ranbir Kapoor as Lord Ram, Yash as Ravana, and a score by A.R. In a bold attempt to reframe how Indian epics are viewed on the world stage, Ramayana producer Namit Malhotra is setting out to deliver more than just a film — he's crafting a cinematic spectacle that aims to redefine India's cultural identity in global cinema. With an ensemble cast led by Ranbir Kapoor and an extraordinary cross-continental collaboration between AR Rahman and Hans Zimmer , this mythological epic promises to be one of the most ambitious projects in Indian film history. Speaking on a podcast with Prakhar Gupta, Namit revealed that his childhood love for cinema—especially Jurassic Park—ignited his dream to create something epic. 'When Jurassic Park came out, I was in awe… It made me want to be a filmmaker, to build worlds,' he recalled, reflecting on the film's lasting impact. However, it was during the recent Hollywood writers' strike that the producer found a rare pause—one that allowed him to reflect not just on his own journey, but also on the way Indian stories have been represented on the global stage. He also observed that many Indian stories which gained global acclaim—such as Slumdog Millionaire, Gandhi, Lion, and even RRR—often portrayed Indians through themes of poverty or struggle. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Arvonnassa joululoma Berliiniin kahdelle Lue lisää Undo While he acknowledged their success, he felt these narratives didn't reflect the strength and richness of Indian culture. This realisation led him to choose Ramayana as the story to bring to the global stage, aiming to highlight India's civilisational legacy with pride and scale. Namit, the powerhouse behind visual effects for Hollywood epics like Dune, Oppenheimer, Inception, and Interstellar, is now stepping into the creative limelight with Ramayana. Through Prime Focus and DNEG, he's helped shape cinematic history — but with this mythological magnum opus, he's determined to reshape global perceptions of Indian cinema and storytelling. Ramayana is poised to be a cinematic spectacle told in two parts, with Part 1 slated for a Diwali 2026 release and Part 2 following in 2027. The film features a star-studded cast — Ranbir Kapoor as Lord Ram, Yash as Ravana, Sai Pallavi as Sita, Ravie Dubey as Laxmana, and Sunny Deol as Hanuman. Elevating its global ambition is an unprecedented musical collaboration between A.R. Rahman and Hollywood maestro Hans Zimmer, who marks his Bollywood debut with the film's score.


Pink Villa
2 days ago
- Entertainment
- Pink Villa
Jurassic World Rebirth hits USD 532 million in 13 days at global box office, Scarlett Johansson's movie continues its glorious run
Gareth Edwards' directorial, Jurassic World: Rebirth has been ruling at the global box office. Written by David Koepp, the Hollywood movie stars Scarlett Johansson, who plays the lead role. Released on July 2, 2025, Jurassic World: Rebirth has earned USD 532 million in 13 days at the worldwide box office. Jurassic World: Rebirth earns USD 532 million worldwide in 13 days Backed under the banner of Universal Pictures, Jurassic World Rebirth collected USD 232.4 million in domestic markets. As far as international collection is concerned, the Scarlett Johansson starrer recorded a gross business of USD 300.2 million. The cume worldwide earnings of Jurassic World: Rebirth now stands at USD 532.6 million gross in 13 days. All you should know about Jurassic World: Rebirth Jurassic World: Rebirth entered the USD 500 million club by the end of its second weekend at the global box office. It is one of the highest grossing films of 2025. The science fiction action thriller is expected to continue its glorious run in theaters in the coming weeks. It is yet to be seen if Gareth Edwards' directorial can touch the USD 1 billion mark globally while reaching the finish line. Scarlett Johansson 's movie is the fourth part of the Jurassic World film series. It is also the seventh installment in the Jurassic Park franchise. The new release also stars Mahershala Ali, Jonathan Bailey, Rupert Friend, Manuel Garcia-Rulfo, and Ed Skrein in pivotal roles. Jurassic World: Rebirth marks the standalone sequel to Jurassic World Dominion, which was released in 2022. It is competing with Hollywood releases, Superman and F1: The Movie at the worldwide box office. Jurassic World: Rebirth In Theatres Jurassic World: Rebirth plays in theatres. Stay tuned to Pinkvilla for more updates. Disclaimer: The box office figures are compiled from various sources and our research. The figures can be approximate, and Pinkvilla does not make any claims about the authenticity of the data. However, they are adequately indicative of the box-office performance of the films in question.


Time of India
2 days ago
- Entertainment
- Time of India
Ranbir Kapoor-Yash starrer Ramayana to be India's costliest film ever at Rs 4000 crore, says producer Namit Malhotra: ‘We're funding it ourselves'
Producer Namit Malhotra is set to rewrite the rules of Indian cinema with his upcoming magnum opus Ramayana , a two-part epic starring Ranbir Kapoor as Lord Ram and featuring a stellar cast including Yash , Amitabh Bachchan, Sai Pallavi , and Sunny Deol . What's grabbing global attention, however, is the jaw-dropping budget: $500 million or approximately Rs 4000 crore, making it the most expensive Indian film ever made. 'We're not taking anybody's money' In a recent conversation with Prakhar Gupta, Namit Malhotra, the CEO of Prime Focus and the force behind several Hollywood blockbusters like Inception, Interstellar, and Dune, opened up about the ambitious scale of Ramayana and why it's a personal mission. 'We're funding it ourselves. We're not taking anybody's money,' Malhotra asserted. 'People thought I was crazy when we started six-seven years ago, just after the pandemic. No Indian film had come close to this kind of budget.' He estimates that by the time both parts are completed, the production cost will be around $500 million, a figure that rivals, if not undercuts, some of the biggest Hollywood tentpole movies. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like [국가인증] 키성장 인증받은 '이 제품' 2개월치 무료증정 이벤트 곧 마감! 아이클타임 더 알아보기 Undo 'We are making the largest film in the world for the greatest story, the greatest epic that the world should see. And I still think it's cheaper than it costs to make some of the biggest Hollywood films,' he added. A childhood dream born from Jurassic Park Malhotra traced the origin of his vision to a childhood encounter with Jurassic Park, a film that opened his imagination to the possibilities of building believable fictional worlds. Though he never became a director, he built a global post-production and visual effects powerhouse with Prime Focus, contributing to several Oscar-winning projects. But there was one lingering frustration: the lack of global respect for Indian cinema. Sunny Deol to Play 'Lord Hanuman' in 'Ramayana'| Gets '15 Minutes of High-Octane Screen Time' 'All the films they saw us as were victims and we were poor and always less fortunate and treated poorly by the world. And I was like, no, that's not who we are. That's not the country I come from,' he said. This disconnect became the driving force behind Ramayana. Malhotra aims to present India's spiritual and cultural heritage to the world through the story he calls 'the greatest epic of all time.' Diwali 2026: The beginning of something epic With Ramayana Part 1 slated to release on Diwali next year, anticipation is at fever pitch. Helmed by acclaimed director Nitesh Tiwari (Dangal, Chhichhore), the film is expected to combine high-end VFX, emotional storytelling, and unparalleled scale, marking a new chapter in Indian cinematic history. If Malhotra's vision delivers, Ramayana could not only set box office records but also redefine how Indian mythology is presented to a global audience.


The Sun
3 days ago
- Entertainment
- The Sun
Superman dominates North American box office with $122M debut
LOS ANGELES: The latest Superman film has claimed the top spot at the North American box office, earning an impressive $122 million in its opening weekend. Directed by James Gunn, the Warner Bros and DC Studios production introduces David Corenswet as the new Man of Steel, alongside Rachel Brosnahan as Lois Lane. Analyst David A. Gross of Franchise Entertainment Research noted, 'This is an outstanding domestic opening for the 7th episode in a superhero story that's been filmed for over 75 years.' He added, 'Mr Gunn chose not to rely on big stars. The storytelling and filmmaking are doing the work here.' In second place, Jurassic World: Rebirth collected $40 million in its second week. The Universal Pictures sequel, starring Scarlett Johansson and Mahershala Ali, revisits the abandoned island from the original Jurassic Park. Brad Pitt's F1: The Movie secured third place with $13 million, while Universal and DreamWorks' live-action How to Train Your Dragon reboot landed in fourth with $7.8 million. Disney/Pixar's Elio rounded out the top five with $3.9 million. Other notable performers included 28 Years Later ($2.73 million), Lilo & Stitch ($2.7 million), and Mission: Impossible – The Final Reckoning ($1.5 million). Gross observed, 'It's summertime and the big pictures are loud and visually dazzling: 'Superman,' 'Jurassic,' 'F1,' and 'How to Train Your Dragon'. Audiences want to be transported and taken away, and they're getting what they want.' - AFP

Straits Times
3 days ago
- Science
- Straits Times
Fact or fiction: Can freezing animal cells help bring species back if they go extinct?
Sign up now: Get ST's newsletters delivered to your inbox Frozen cell and tissue samples of flora and fauna are stored in cryopreservation vats at the NUS Lee Kong Chian Natural History Museum. SINGAPORE - Biobanking is the preservation of biological material from animals, plants and other living matter, often via storage at sub-zero temperatures. Though initially used for clinical research, biobanks have recently been used as a tool for wildlife conservation. Singapore has two conservation biobanks , which are overseen by the NUS Lee Kong Chian Natural History Museum and Mandai Wildlife Group. Science fiction films like Jurassic Park allude to the potential of using the genetic information of extinct animals to bring them back to life. The Straits Times spoke with the museum's scientists to dispel some common myths about the technology. Mr Marcus Chua is the museum's mammal curator, while Mr Foo Maosheng oversees its insect and cryogenic collections. Myth: Freezing tissues and cells to below 0 deg C will prevent them from degrading. Fact: Degradation stops only in samples kept at or below minus 130 deg C, with most cryopreservation vats set to minus 180 deg C or lower. Cellular activity ceases at these ultra-low temperatures, hence preserving the integrity of proteins, genetic material and other cell components stored within the vats. If samples are stored in fridges set to minus 20 or minus 80 deg C, degradation is slowed, but will still occur. Top stories Swipe. Select. Stay informed. Singapore Govt will continue to support families, including growing group of seniors: PM Wong at PCF Family Day Singapore From Normal stream to Parliament: 3 Singapore politicians share their journeys World Deal or no deal? EU faces critical decision in response to Trump's latest tariff salvo Singapore Segregated recycling bins found to lower contamination rate as more spring up Sport Two participants injured after another breached safety protocol during Pesta Sukan archery event Asia Mahathir discharged from hospital after feeling fatigued during birthday gathering Singapore Medics treat 7 after blaze at HDB block lift lobby in Chai Chee Singapore I lost my daughter to Kpod addiction: Father of 19-year-old shares heartbreak and lessons Myth: It does not matter how cells and tissues are frozen, as long as they are brought to sub-zero temperatures. Fact: The freezing process can cause damage to the fragile biological tissue, for example, when ice crystals form, so care must be taken to ensure the genetic information remains intact. The museum follows a rapid freezing protocol, where small tubes of samples are directly dipped into liquid nitrogen, then stored within cryopreservation vats. This method of flash freezing leads to much tinier ice crystals, minimising the damage to the cells' integrity. For Mandai Wildlife Group, it also has to ensure that the stored cells remain viable, meaning that they can continue to grow and replicate after they are thawed. Key to this is preventing the formation of ice crystals, which could damage DNA or tissues. Keeping samples at higher temperatures could cause ice crystals to form. Anti-freeze is also added during the freezing process to prevent ice crystals from forming. More on this topic Coral frozen in time throws lifeline for Great Barrier Reef Myth: The applications of biobanking are mostly for research. Fact: Biobanking yields very tangible, real-world benefits in the realm of conservation. One example is if you want to re-introduce a species that is extirpated – extinct in a geographical region – and are looking for a source of individuals to introduce. If you have a banked sample of the animal's cells or tissues, you can pull it out and find its genetic stock, then go out and find the closest related ones in the wild. Myth: This technology can be used to bring extinct animals back to life, like in Jurassic Park. Fact: This could be possible with further developments in stem cell technology, although researchers say it would require careful consideration of the ethics involved in biobanking. Efforts to de-extinct species – or bring back animals no longer in existence today – are often costly, and consume money and resources which could otherwise be funnelled to other causes, such as conserving currently endangered species. Whether or not organisms are indeed 'brought back to life' by de-extinction initiatives is also highly debated. An example of this was when Dallas-based biotech company Colossal Biosciences claimed they had 'resurrected' the dire wolf – by partially altering the genome of the modern grey wolf.